Circulating immune cell dynamics in patients with triple negative breast cancer treated with neoadjuvant chemotherapy

by Sarah Talamantes, Eric Xie, Ricardo L. B. Costa, Melissa Chen, Alfred Rademaker, Cesar A. Santa‐Maria
Published 2020-10-01

In silico simulation of a clinical trial with anti-CTLA-4 and anti-PD-L1 immunotherapies in metastatic breast cancer using a systems pharmacology model

by Hanwen Wang, Oleg Milberg, Imke H. Bartelink, Paolo Vicini, Bing Wang, Rajesh Narwal, Lorin Roskos, Cesar A. Santa-Maria, Aleksander S. Popel
Published 2019-05-01

Phase II study of pembrolizumab and capecitabine for triple negative and hormone receptor-positive, HER2−negative endocrine-refractory metastatic breast cancer

by Ami N Shah, Lisa Flaum, Irene Helenowski, Cesar A Santa-Maria, Sarika Jain, Alfred Rademaker, Valerie Nelson, Dean Tsarwhas, Massimo Cristofanilli, William Gradishar
Published 2020-06-01